We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Skyworks Solutions
SWKS
$10.1B
| $34.7M | 0.07% |
465,307
+202,205
| +77% | +$13.5M |
|
327
Humana
HUM
$47.1B
| $34.5M | 0.06% |
140,956
+57,680
| +69% | +$14.4M |
|
328
Citigroup
C
$223B
| $34.3M | 0.06% |
403,148
-2,461
| -0.6% | -$178K |
|
329
Fair Isaac
FICO
$25B
| $34.2M | 0.06% |
18,694
+6,429
| +52% | +$12.1M |
|
330
Samsara
IOT
$24.4B
| $34.1M | 0.06% |
858,266
+132,268
| +18% | +$5.47M |
|
331
Public Storage
PSA
$58.1B
| $33.8M | 0.06% |
115,318
-9,245
| -7% | -$2.74M |
|
332
Norwegian Cruise Line
NCLH
$7.65B
| $33.7M | 0.06% |
1,659,890
+210,073
| +14% | +$3.76M |
|
333
SL Green Realty
SLG
$4.1B
| $33.6M | 0.06% |
543,026
+19,844
| +4% | +$1.14M |
|
334
Marvell Technology
MRVL
$217B
| $33.1M | 0.06% |
427,370
-195,997
| -31% | -$12.2M |
|
|
WAY
335
Waystar Holding Corp
WAY
$4.84B
| $32.8M | 0.06% |
801,718
+157,024
| +24% | +$6.05M |
|
336
GitLab
GTLB
$7.57B
| $32.6M | 0.06% |
721,714
+130,687
| +22% | +$5.98M |
|
337
Procept Biorobotics
PRCT
$1.18B
| $32.5M | 0.06% |
565,083
+25,863
| +5% | +$1.46M |
|
338
IBM
IBM
$225B
| $32.4M | 0.06% |
109,813
+2,671
| +2% | +$688K |
|
339
Powell Industries
POWL
$7.02B
| $32M | 0.06% |
456,354
+86,307
| +23% | +$5.21M |
|
340
Willis Towers Watson
WTW
$31.5B
| $32M | 0.06% |
104,370
+1,582
| +2% | +$491K |
|
341
VICI Properties
VICI
$28.4B
| $32M | 0.06% |
980,562
-239,623
| -20% | -$7.63M |
|
342
Bilibili
BILI
$7.02B
| $31.8M | 0.06% |
1,480,287
+133,828
| +10% | +$2.46M |
|
343
Medtronic
MDT
$115B
| $31.5M | 0.06% |
361,932
-515
| -0.1% | -$43.7K |
|
344
Service Corp International
SCI
$11.4B
| $31.5M | 0.06% |
387,330
-116,253
| -23% | -$9.08M |
|
345
Elanco Animal Health
ELAN
$12.2B
| $31.2M | 0.06% |
2,181,580
+15,825
| +0.7% | +$185K |
|
346
Lam Research
LRCX
$399B
| $30.9M | 0.06% |
317,034
-273,816
| -46% | -$21.7M |
|
347
Aflac
AFL
$58.4B
| $30.8M | 0.06% |
291,656
+287,362
| +6,692% | +$30.2M |
|
348
Bio-Rad Laboratories Class A
BIO
$10.4B
| $30.7M | 0.06% |
127,058
-13,192
| -9% | -$3.12M |
|
349
Microchip Technology
MCHP
$41B
| $30.4M | 0.06% |
431,775
+394,949
| +1,072% | +$21.7M |
|
|
CFLT
350
DELISTED
Confluent
CFLT
| $30.4M | 0.06% |
1,218,100
| – | – |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.